EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Mass spectrometry in ocular drug research

Eva M Del Amo iD, Kati-Sisko Vellonen, Arto Urtti, Tetsuya Terasaki, Anam Hammid, Paavo Honkakoski, Seppo Auriola iD

Mass Spectrometry Reviews · 2026-01 · 45 (1) · 37-68

DOI: 10.1002/mas.21861 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Mass Spectrometry Reviews, online erschienen am 02.08.2023. Verfasst von Eva M Del Amo und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, University of Eastern Finland, Kuopio, Finland. Hauptthemen laut MEDLINE: Mass Spectrometry, Eye. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 197 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mass spectrometry (MS) has been proven as an excellent tool in ocular drug research allowing analyzes from small samples and low concentrations. This review begins with a short introduction to eye physiology and ocular pharmacokinetics and the relevance of advancing ophthalmic treatments. The second part of the review consists of an introduction to ocular proteomics, with special emphasis on targeted absolute quantitation of membrane transporters and metabolizing enzymes. The third part of the review deals with liquid chromatography–MS (LC‐MS) and MS imaging (MSI) methods used in the analysis of drugs and metabolites in ocular samples. The sensitivity and speed of LC‐MS make simultaneous quantitation of various drugs and metabolites possible in minute tissue samples, even though ocular sample preparation requires careful handling. The MSI methodology is on the verge of becoming as important as LC‐MS in ocular pharmacokinetic studies, since the spatial resolution has reached the level, where cell layers can be separated, and quantitation with isotope‐labeled standards has come more reliable. MS will remain in the foreseeable future as the main analytical method that will progress our understanding of ocular pharmacokinetics.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mass SpectrometryEyeHumansChromatography, LiquidAnimalsProteomicsPharmaceutical PreparationsAdministration, OphthalmicPharmacokinetics

Stichwörter der Autor:innen

LC‐MS/MSMSIdrug analysismass spectrometryocular pharmacokineticsproteomicsquantitationspatial distribution

Substanzen

Pharmaceutical Preparations

Autor:innen und Institutionen

  • School of Pharmacy, University of Eastern Finland, Kuopio, Finland.
  • Division of Pharmaceutical Biosciences, Faculty of Pharmacy, University of Helsinki, Helsinki, Finland.

ORCID-Profile: Eva M Del Amo, Seppo Auriola

Zitieren

APA

Del Amo, E. M., Vellonen, K. S., Urtti, A., Terasaki, T., Hammid, A., Honkakoski, P., & Auriola, S. (2026). Mass spectrometry in ocular drug research. Mass Spectrometry Reviews, 45(1), 37-68. https://doi.org/10.1002/mas.21861

Vancouver

Del Amo EM, Vellonen KS, Urtti A, Terasaki T, Hammid A, Honkakoski P, et al. Mass spectrometry in ocular drug research. Mass Spectrometry Reviews. 2026;45(1):37-68. doi:10.1002/mas.21861

BibTeX
@article{DelAmo2026,
  author = {Del Amo, Eva M and Vellonen, Kati-Sisko and Urtti, Arto and Terasaki, Tetsuya and Hammid, Anam and Honkakoski, Paavo and Auriola, Seppo},
  title = {Mass spectrometry in ocular drug research},
  journal = {Mass Spectrometry Reviews},
  year = {2026},
  volume = {45},
  number = {1},
  pages = {37--68},
  doi = {10.1002/mas.21861}
}
Kostenlos starten →